Kuo‐Chin Chang

1.9k total citations
82 papers, 1.4k citations indexed

About

Kuo‐Chin Chang is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Kuo‐Chin Chang has authored 82 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Epidemiology, 68 papers in Hepatology and 12 papers in Surgery. Recurrent topics in Kuo‐Chin Chang's work include Liver Disease Diagnosis and Treatment (62 papers), Hepatitis C virus research (54 papers) and Hepatitis B Virus Studies (47 papers). Kuo‐Chin Chang is often cited by papers focused on Liver Disease Diagnosis and Treatment (62 papers), Hepatitis C virus research (54 papers) and Hepatitis B Virus Studies (47 papers). Kuo‐Chin Chang collaborates with scholars based in Taiwan, United States and China. Kuo‐Chin Chang's co-authors include Tsung‐Hui Hu, Po‐Lin Tseng, Chien‐Hung Chen, Sheng‐Nan Lu, Ming‐Chao Tsai, Yi‐Hao Yen, Jing‐Houng Wang, Chao‐Hung Hung, Kwong‐Ming Kee and Ming‐Tsung Lin and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

Kuo‐Chin Chang

80 papers receiving 1.4k citations

Peers

Kuo‐Chin Chang
John Boitnott United States
Faisal M. Sanai Saudi Arabia
Geri Brown United States
M.P. Manns Germany
John Boitnott United States
Kuo‐Chin Chang
Citations per year, relative to Kuo‐Chin Chang Kuo‐Chin Chang (= 1×) peers John Boitnott

Countries citing papers authored by Kuo‐Chin Chang

Since Specialization
Citations

This map shows the geographic impact of Kuo‐Chin Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuo‐Chin Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuo‐Chin Chang more than expected).

Fields of papers citing papers by Kuo‐Chin Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuo‐Chin Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuo‐Chin Chang. The network helps show where Kuo‐Chin Chang may publish in the future.

Co-authorship network of co-authors of Kuo‐Chin Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Kuo‐Chin Chang. A scholar is included among the top collaborators of Kuo‐Chin Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuo‐Chin Chang. Kuo‐Chin Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yap, Desmond Y. H., Cheng‐Kun Wu, Colin Tang, et al.. (2025). A long term bone and renal safety of TAF treatment on renal transplant recipients. Biomedical Journal. 48(6). 100833–100833.
2.
Hu, Tsung‐Hui, Yeh‐Pin Chou, Yuan‐Hung Kuo, et al.. (2023). Long-term comparisons of the durability of 6 months versus 12 months antiviral therapy for hepatitis B after chemotherapy cessation. Journal of Infection and Public Health. 16(11). 1852–1859. 1 indexed citations
3.
Hu, Tsung‐Hui, Sherry Yueh‐Hsia Chiu, Po‐Lin Tseng, et al.. (2020). Five‐year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment‐naïve patients with chronic hepatitis B‐related compensated cirrhosis in Taiwan. Alimentary Pharmacology & Therapeutics. 52(11-12). 1695–1706. 14 indexed citations
4.
Yen, Yi‐Hao, Pao‐Yuan Huang, Chih‐Che Lin, et al.. (2019). The Pre- and Postoperative FIB-4 Indexes Are Good Predictors to the Outcomes of HBV-Related HCC Patients after Resection. Gastroenterology Research and Practice. 2019. 1–9. 3 indexed citations
5.
Yen, Yi‐Hao, Fang‐Ying Kuo, Kwong‐Ming Kee, et al.. (2018). Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients. Digestive and Liver Disease. 51(1). 142–148. 2 indexed citations
6.
Yen, Chih‐Wei, Yuan‐Hung Kuo, Jing‐Houng Wang, et al.. (2018). Did AFP‐L3 save ultrasonography in community screening?. The Kaohsiung Journal of Medical Sciences. 34(10). 583–587. 5 indexed citations
7.
Yen, Yi‐Hao, Ming‐Tsung Lin, Fang‐Ying Kuo, et al.. (2017). The association between steatosis and diabetes with hepatocellular carcinoma in non‐genotype 3 chronic hepatitis C patients. Liver International. 38(6). 1064–1073. 14 indexed citations
8.
Hu, Tsung‐Hui, Kuo‐Chin Chang, Po‐Lin Tseng, et al.. (2017). Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy. Medicine. 96(46). e8696–e8696. 9 indexed citations
9.
Yen, Yi‐Hao, Jung‐Fu Chen, Cheng‐Kun Wu, et al.. (2017). The correlation of controlled attenuation parameter results with ultrasound-identified steatosis in real-world clinical practice. Journal of the Formosan Medical Association. 116(11). 852–861. 10 indexed citations
10.
Yen, Yi‐Hao, Kuo‐Chin Chang, Ming‐Chao Tsai, et al.. (2017). Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease. Journal of the Formosan Medical Association. 117(4). 268–275. 17 indexed citations
11.
Wu, Cheng‐Kun, Kuo‐Chin Chang, Chao‐Hung Hung, et al.. (2016). Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy. Journal of Antimicrobial Chemotherapy. 71(7). 1943–1947. 20 indexed citations
12.
Kuo, Yuan‐Hung, Ming‐Chao Tsai, Kwong‐Ming Kee, et al.. (2016). Associated Factors for Metabolic Syndrome in the Older Adults with Chronic Virus Hepatitis in the Community. PLoS ONE. 11(5). e0155544–e0155544. 7 indexed citations
13.
Kuo, Yuan‐Hung, Jing‐Houng Wang, Kuo‐Chin Chang, et al.. (2015). Comparison Stratagems of Post-Screening Management of Anti-HCV-Positive Community Residents: Simple Notification, Active Referral, or Accessible Medical Care. PLoS ONE. 10(5). e0126031–e0126031. 10 indexed citations
14.
Tsai, Ming‐Chao, Chia‐Hsiang Chen, Po‐Lin Tseng, et al.. (2015). Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience. Clinical Microbiology and Infection. 22(1). 95.e1–95.e7. 50 indexed citations
15.
Tai, Wei‐Chen, Ming‐Tsung Lin, Tsung‐Hui Hu, et al.. (2014). Levofloxacin-containing second-line anti-Helicobacter pylori eradication in Taiwanese real-world practice. Biomedical Journal. 37(5). 326–326. 23 indexed citations
16.
Tsai, Ming‐Chao, C.-M. Lee, King‐Wah Chiu, et al.. (2011). A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice. Journal of Antimicrobial Chemotherapy. 67(3). 696–699. 25 indexed citations
17.
Tung, Hung‐Da, Jing‐Houng Wang, Po‐Lin Tseng, et al.. (2010). Neither Diabetes Mellitus nor Overweight Is a Risk Factor for Hepatocellular Carcinoma in a Dual HBV and HCV Endemic Area: Community Cross-Sectional and Case–Control Studies. The American Journal of Gastroenterology. 105(3). 624–631. 41 indexed citations
18.
Tai, Wei‐Chen, Seng-Kee Chuah, Chao‐Cheng Huang, et al.. (2008). Liver Tuberculosis in Southern Taiwan: 15-years Clinical Experience. 19(5). 410–417. 11 indexed citations
19.
Chang, Kuo‐Chin, Seng-Kee Chuah, Chi‐Sin Changchien, et al.. (2006). Clinical characteristics and prognostic factors of splenic abscess: A review of 67 cases in a single medical center of Taiwan. World Journal of Gastroenterology. 12(3). 460–460. 146 indexed citations
20.
Chang, Kuo‐Chin, Chi‐Sin Changchien, Yi‐Chun Chiu, et al.. (2005). Clinical Analysis of the Efficacy in Lipase/Amylase Ratio for Acute Pancreatitis. 16(3). 113–120. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026